Description
The anti-Peptide L4 (RGYLYQGL) TCR Jurkat cell line is a stable cell line made from the anti-Peptide L4 TCR lentivirus. The recombinant Jurkat T cell was designed to predict the MOA of Peptide L4-TCR, measure the Peptide L4-TCR specificity and screen target cells expressing Peptide L4. And the product can be used to treat cytomegalovirus infection